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Background
• Lung cancer, the leading cause of cancer-related death, is associated with poor survival; painful, life-threatening disease-related attributes; and an economic burden greater than other cancers 1, 2 • Non-small cell lung cancer (NSCLC), the most common type of lung cancer, presents multiple challenges for patients' caregivers, including increased distress, significant impact on social and healthrelated quality of life (HRQoL), and costs associated with loss of income and time spent on patient care [2] [3] [4] • Caregivers for elderly patients with lung cancer are often children in the prime of their productivity to society • Respondents who reported being caregivers for an adult relative with lung cancer ("caregivers") were compared with those who were not caregivers for a relative with any condition ("non-caregivers")
• Indirect costs were estimated for each respondent using the human capital method, which assesses the degree to which caregiving for a patient with lung cancer is associated with impairment to an individual's productivity
• Measures and survey instruments are described in 
Sociodemographics and Health Characteristics
• Caregivers and non-caregivers were on average 44.1 and 46.3 years old, respectively, and employed (55.1% and 57.4%, respectively), suggesting care is more commonly provided by children rather than by a spouse/partner
• In bivariate analyses, no significant differences between caregivers and non-caregivers on sociodemographic and health characteristics (eg, similar non-smoking rates)
Health-related Quality of Life • Adjusting for covariates, caregivers compared with non-caregivers reported significantly worse HRQoL as measured by the physical component summary (PCS) score, mental component summary (MCS) score, and SF-6D health utilities, based on the SF-12v2 (Figure 1) • Caregivers also reported significantly worse HRQoL in all subscales of the SF-12v2 except vitality (ie, bodily pain, general health, mental health, physical functioning, role emotional, role physical, and social functioning)
Stress-related Comorbidities
• Adjusting for covariates, caregivers of lung cancer patients compared with non-caregivers reported significantly higher odds of being diagnosed with depression, insomnia, headache, and GI symptoms (Figure 2) Work Productivity and Activity Impairment • Adjusting for covariates, caregivers compared with non-caregivers reported significantly higher mean levels of presenteeism-related impairment, overall work impairment, and activity impairment during the last week (Figure 3) • Adjusting for covariates, caregivers compared with non-caregivers 
Conclusions Summary
• Caregivers for patients with lung cancer, versus non-caregivers, reported significantly lower mental and physical health status, lower health utilities, higher stress-related comorbidities (depression, insomnia, headache, and GI problems), impaired work productivity and activity, and higher indirect costs due to work productivity impairment -Based on average age and employment status, it appears that children/caregivers of elderly lung patients have substantial reductions in productivity compared with non-caregivers -In spite of higher levels of morbidity, caregivers' healthcare resource use was not higher than that of non-caregivers; the extent to which the excess morbidity of caregivers is addressed by appropriate healthcare resources requires further investigation
• There is an apparent need for increased personalized support for caregivers for patients with lung cancer
• Additional research on other aspects of caregiver burden, such as healthcare resource utilization and work productivity, will help refine estimation of the financial impact of lung cancer on society
• Given the inevitable growing demand on informal care in cancer, consideration of the caregiving experience is needed in clinical research, practice, and policy programs, as well as in the estimation of the value for money of new cancer therapies
Limitations
• Use of retrospective, cross-sectional data, and an Internet-based sample of caregivers that may not be truly representative for the entire population
• Lack of assessment of cancer status, histology, and treatments CCI is a method for classifying comorbid conditions to predict mortality, with higher scores indicating increased risk of mortality b means beta, which represents the change in the outcome variable associated with a 1-unit change in the covariate a Minimally important differences (MIDs) equal ~3 points for PCS and MCS and ~0.03 points for SF-6D health utilities. 10, 11 Differences exceeding MID reflect differences found to be meaningful in previous research. 
